CTI Life Sciences Fund
Montreal, Canada · Pre-seed → Series C+
Their stated focus (public profile)
CTI Life Sciences Fund is a biotech-focused venture capital firm that acts as a company builder, catalyzing nascent ideas and assets into investable, scalable, and marketable biotech companies. The fund is therapeutic and modality agnostic, pursuing a dual-pronged investment strategy focused on both long-term value creation and expedited exit timelines. It targets strategic acquirers who will pay a premium for best-in-class assets or platforms, with a track record of 30+ investments, 5 regulatory approvals, and 10+ exits over 20+ years.
Stages: Pre-seed → Series C+
Sectors: Life sciences, Cardiology
On file: 7 partners on record · 13 companies on record
Website: ctisciences.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.